Organon & Co | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Adcock Ingram Holdings ZAR 997.56M 6.08M 2024-06
Bristol-Myers Squibb USD 2.1B 129M 2024-12
Celltrion KRW 239.71B 17.94B 2024-09
Cspc Pharmaceutical CNY 2.1B 22.82M 2024-09
Dianthus Therapeutics USD 6.54M 530K 2024-09
Ecofibre AUD 8.03M 1.38M 2024-06
Gilead Sciences USD 1.86B 451M 2024-12
Glaxosmithkline GBP 2.7B 632M 2024-12
Kangmei Pharma CNY 245.26M 66.07M 2024-09
Knight Therapeutics CAD 25.48M 119K 2024-09
Laboratorios Farma EUR 32.57M 26.69M 2024-06
Malin Corporation EUR 700K 1.6M 2024-06
Medical Developments International AUD 7.07M 15.4M 2024-06
Merck USD 2.85B 148M 2024-12
Neuren Pharmaceuticals AUD 2.33M 47K 2024-12
Novartis USD 3.5B 368M 2024-12
Organigram Holdings CAD 17.19M 2.88M 2024-12
Organon & Co USD 470M 48M 2024-12
Pharma Mar EUR 13.23M 2.55M 2024-12
Qiagen NV USD 141.71M 1.05M 2024-12
Sartorius EUR 216.7M 8.5M 2024-09
Sino Biopharmaceutical CNY 3.42B 1.2B 2024-06
Tilray USD 72.38M 4.99M 2024-11



Organon & Co Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.